Sanofi, poised to rival Roche in hemophilia, nabs FDA approval for Altuviiio zbecker Thu, 02/23/2023 – 15:45 More: Sanofi, poised to rival Roche in hemophilia, nabs FDA approval for Altuviiio Source: fierce
read moreIn antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics zbecker Thu, 02/23/2023 – 12:15 More: In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics Source: fierce
read moreAfter splashing $1B, Roche returns lagging cancer drug Gavreto to Blueprint Medicines aliu Thu, 02/23/2023 – 11:14 More: After splashing B, Roche returns lagging cancer drug Gavreto to Blueprint Medicines Source: fierce
read moreWarren urges US patent office to scrutinize Merck’s efforts with Keytruda kdunleavy Thu, 02/23/2023 – 11:05 More: Warren urges US patent office to scrutinize Merck's efforts with Keytruda Source: fierce
read moreAs commercial COVID pivot looms, Moderna logs $2.8B in demand-related expenses fkansteiner Thu, 02/23/2023 – 10:24 More: As commercial COVID pivot looms, Moderna logs .8B in demand-related expenses Source: fierce
read morePhase 1/2 research shows that treatment could be very effective against Fabry disease More: Sangamo’s ST-920 demonstrates evidence of clinical benefit Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals